Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Awad

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Stroke and Vascular Neurology|November 10, 2023
Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhageYunke Li, Sung-Min Cho, Radhika Avadhani, et al.
Neurocritical Care|January 3, 2018
The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III TrialAchim Müller, W Andrew Mould, W David Freeman, et al.
Stroke|December 5, 2013
Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformationsAbdul Ghani Mikati, Huan Tan, Robert Shenkar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2020
Prior antiplatelet therapy and haematoma expansion after primary intracerebral haemorrhage: an individual patient-level analysis of CLEAR III, MISTIE III and VISTA-ICHSantosh Murthy, David J Roh, Abhinaba Chatterjee, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 24, 2026
Functional and Patient-reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory StudyGeorgeio Sader, Roberto J Alcazar-Felix, Aditya Jhaveri, et al.
Stroke|February 9, 2013
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edemaW Andrew Mould, J Ricardo Carhuapoma, John Muschelli, et al.
Neurology|June 30, 2017
Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trialSantosh B Murthy, Issam Awad, Sagi Harnof, et al.
Stroke|February 2, 2013
The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcomeTimothy C Morgan, Jesse Dawson, Danielle Spengler, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|December 5, 2024
Fourth-generation Pipeline<sup>™</sup> Vantage flow diversion: First reported US experience of safety and feasibilityAhmad Sweid, Ahmad Chahine, Stephanie Hage, et al.
Stroke|August 27, 2011
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trialNeal Naff, Michael A Williams, Penelope M Keyl, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Stroke and Vascular Neurology|November 10, 2023
Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhageYunke Li, Sung-Min Cho, Radhika Avadhani, et al.
Neurocritical Care|January 3, 2018
The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III TrialAchim Müller, W Andrew Mould, W David Freeman, et al.
Stroke|December 5, 2013
Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformationsAbdul Ghani Mikati, Huan Tan, Robert Shenkar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2020
Prior antiplatelet therapy and haematoma expansion after primary intracerebral haemorrhage: an individual patient-level analysis of CLEAR III, MISTIE III and VISTA-ICHSantosh Murthy, David J Roh, Abhinaba Chatterjee, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 24, 2026
Functional and Patient-reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory StudyGeorgeio Sader, Roberto J Alcazar-Felix, Aditya Jhaveri, et al.
Stroke|February 9, 2013
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edemaW Andrew Mould, J Ricardo Carhuapoma, John Muschelli, et al.
Neurology|June 30, 2017
Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trialSantosh B Murthy, Issam Awad, Sagi Harnof, et al.
Stroke|February 2, 2013
The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcomeTimothy C Morgan, Jesse Dawson, Danielle Spengler, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|December 5, 2024
Fourth-generation Pipeline<sup>™</sup> Vantage flow diversion: First reported US experience of safety and feasibilityAhmad Sweid, Ahmad Chahine, Stephanie Hage, et al.
Stroke|August 27, 2011
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trialNeal Naff, Michael A Williams, Penelope M Keyl, et al.
Pageof 5